The Infection Innovation Consortium (iiCON), a leading global centre of infectious disease innovation and R&D, has appointed us, Studio Coact, to deliver its new website following a competitive tender process.
Led by founding Director, Professor Janet Hemingway of Liverpool School of Tropical Medicine, iiCON brings together industry, researchers, and the NHS. The consortium is working to save millions of lives world-wide by bringing new, innovative treatments for infectious diseases to patients more quickly, safely, and affordably.
iiCON’s programme is expected to increase spend in infection innovation in the North West by over £1 billion a year over the next ten years – supporting pandemic resilience and establishing the North West as the leading global destination for infectious disease R&D.
We are a studio that works with companies to develop their brands and build digital presence by developing considered marketing strategies. We have designed and built websites for clients including Sensor City, the University of Liverpool, and the NHS.
iiCON’s new website will support the consortium to reach and engage global audiences. It will provide a highly-functional platform that delivers an outstanding user experience. By clearly communicating iiCON’s offering and guiding users to relevant and appropriate information, it will drive engagement and support collaboration.
Neil Foulkes, our founder, said:
“The team and I are delighted to be working with iiCON, supporting them on their mission of cementing the North West as the world’s leading location for developing anti-infectives. It is our mission to build brands and digital experiences for businesses in all sectors, so when the opportunity presented itself, we were very enthusiastic. We’re thrilled to be selected and trusted by iiCON, during such an important step in the consortium’s growth and development.”
Ruth Cobban, communications manager at iiCON, said:
“Studio Coact is an innovative North West company, with a strong track record supporting brands across sectors, including health and life sciences, in delivering high-performing, well-designed, intuitive websites that drive and deepen engagement.”
iiCON’s new site will assist the consortium’s objectives by clearly communicating our offering and providing an intuitive user experience for a diverse global audience, including existing and potential collaborators. We’re delighted to be working with Neil and the team and look forward to launching our new site later this year.
The iiCON consortium comprises LSTM, Liverpool University Hospitals NHS Foundation Trust, Unilever UK, the University of Liverpool, Infex Therapeutics, and Evotec at Alderley Park, Cheshire.